Susquehanna Fundamental Investments, LLC Adverum Biotechnologies, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $24,492 - $33,782	-14,076 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $89,656 - $155,174	-43,104 Reduced 75.38%	14,076 $31,000
Q2 2021 Aug 11, 2021	BUY	$3.36 - $10.56 $192,124 - $603,820	57,180 New	57,180 $200,000
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $592,640 - $919,040	-64,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $74,793 - $108,390	7,601 Added 13.48%	64,000 $694,000
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $293,539 - $616,718	28,499 Added 102.15%	56,399 $581,000
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $237,986 - $715,356	27,900 New	27,900 $583,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.